Cokkinides V, Albano J, Samuels A, Ward M, Thum J. American Cancer Society: cancer facts and figures. Atlanta: American Cancer Society; 2005.

Google Scholar 

Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17–48.

Article  PubMed  Google Scholar 

Buhtoiarova TN, Brenner CA, Singh M. Endometrial carcinoma: role of current and emerging biomarkers in resolving persistent clinical dilemmas. Am J Clin Pathol. 2016;145:8–21.

Article  CAS  PubMed  Google Scholar 

Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet. 2005;366:491–505.

Article  PubMed  Google Scholar 

Janda M, Gebski V, Brand A, Hogg R, Jobling TW, Land R, et al. Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): a randomised trial. Lancet Oncol. 2010;11:772–80.

Article  PubMed  Google Scholar 

Berek JS, Hacker NF. Practical gynecologic oncology. Philadelphia, PA: Lippincott Williams & Wilkins; 2005.

Secord AA, Havrilesky LJ, Bae-Jump V, Chin J, Calingaert B, Bland A, et al. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer. Gynecol Oncol. 2007;107:285–91.

Article  Google Scholar 

Tsoref D, Welch S, Lau S, Biagi J, Tonkin K, Martin LA, et al. Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancer. Gynecol Oncol. 2014;135:184–9.

Article  CAS  PubMed  Google Scholar 

Temkin SM, Fleming G. Current treatment of metastatic endometrial cancer. Cancer Control. 2009;16:38–45.

Article  PubMed  Google Scholar 

Sun H, Enomoto T, Fujita M, Wada H, Yoshino K, Ozaki K, et al. Mutational analysis of the PTEN gene in endometrial carcinoma and hyperplasia. Am J Clin Pathol. 2001;115:32–8.

Article  CAS  PubMed  Google Scholar 

Vilgelm A, Lian Z, Wang H, Beauparlant SL, Klein-Szanto A, Ellenson LH, Di Cristofano A. Akt-mediated phosphorylation and activation of estrogen receptor alpha is required for endometrial neoplastic transformation in Pten+/- mice. Cancer Res. 2006;66:3375–80.

Article  CAS  PubMed  Google Scholar 

Daikoku T, Hirota Y, Tranguch S, Joshi AR, DeMayo FJ, Lydon JP, et al. Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice. Cancer Res. 2008;68:5619–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martin L, Finn CA, Trinder G. Hypertrophy and hyperplasia in the mouse uterus after oestrogen treatment: an autoradiographic study. J Endocrinol. 1973;56:133–44.

Article  CAS  PubMed  Google Scholar 

Huet-Hudson YM, Andrews GK, Dey SK. Cell type-specific localization of c-myc protein in the mouse uterus: modulation by steroid hormones and analysis of the periimplantation period. Endocrinology. 1989;125:1683–90.

Article  CAS  PubMed  Google Scholar 

Wick M, Burger C, Funk M, Muller R. Identification of a novel mitogen-inducible gene (mig-6): regulation during G1 progression and differentiation. Exp Cell Res. 1995;219:527–35.

Article  CAS  PubMed  Google Scholar 

Saarikoski ST, Rivera SP, Hankinson O. Mitogen-inducible gene 6 (MIG-6), adipophilin and tuftelin are inducible by hypoxia. FEBS Lett. 2002;530:186–90.

Article  CAS  PubMed  Google Scholar 

van Laar T, Schouten T, van der Eb AJ, Terleth C. Induction of the SAPK activator MIG-6 by the alkylating agent methyl methanesulfonate. Mol Carcinog. 2001;31:63–7.

Article  PubMed  Google Scholar 

Zhang YW, Staal B, Su Y, Swiatek P, Zhao P, Cao B, et al. Evidence that MIG-6 is a tumor-suppressor gene. Oncogene. 2007;26:269–76.

Article  CAS  PubMed  Google Scholar 

Lin CI, Du J, Shen WT, Whang EE, Donner DB, Griff N, et al. Mitogen-inducible gene-6 is a multifunctional adaptor protein with tumor suppressor-like activity in papillary thyroid cancer. J Clin Endocrinol Metab. 2011;96:E554-565.

Article  CAS  PubMed  Google Scholar 

Ferby I, Reschke M, Kudlacek O, Knyazev P, Pante G, Amann K, et al. Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation. Nat Med. 2006;12:568–73.

Article  CAS  PubMed  Google Scholar 

Amatschek S, Koenig U, Auer H, Steinlein P, Pacher M, Gruenfelder A, et al. Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes. Cancer Res. 2004;64:844–56.

Article  CAS  PubMed  Google Scholar 

Anastasi S, Sala G, Huiping C, Caprini E, Russo G, Iacovelli S, et al. Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin. Oncogene. 2005;24:4540–8.

Article  CAS  PubMed  Google Scholar 

Xu W, Zhu S, Zhou Y, Jin Y, Dai H, Wang X. Upregulation of mitogen-inducible gene 6 triggers antitumor effect and attenuates progesterone resistance in endometrial carcinoma cells. Cancer Gene Ther. 2015;22:536–41.

Article  CAS  PubMed  Google Scholar 

Jeong JW, Lee HS, Lee KY, White LD, Broaddus RR, Zhang YW, et al. Mig-6 modulates uterine steroid hormone responsiveness and exhibits altered expression in endometrial disease. Proc Natl Acad Sci USA. 2009;106:8677–82.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Kim TH, Yoo JY, Kim HI, Gilbert J, Ku BJ, Li J, et al. Mig-6 suppresses endometrial cancer associated with Pten deficiency and ERK activation. Cancer Res. 2014;74:7371–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jeong JW, Lee KY, Kwak I, White LD, Hilsenbeck SG, Lydon JP, DeMayo FJ. Identification of murine uterine genes regulated in a ligand-dependent manner by the progesterone receptor. Endocrinology. 2005;146:3490–505.

Article  CAS  PubMed  Google Scholar 

Kim TH, Yoo JY, Jeong JW. Mig-6 mouse model of endometrial cancer. Adv Exp Med Biol. 2017;943:243–59.

Article  CAS  PubMed  Google Scholar 

Kim TH, Franco HL, Jung SY, Qin J, Broaddus RR, Lydon JP, Jeong JW. The synergistic effect of Mig-6 and Pten ablation on endometrial cancer development and progression. Oncogene. 2010;29:3770–80.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Coll-de la Rubia E, Martinez-Garcia E, Dittmar G, Gil-Moreno A, Cabrera S, Colas E. Prognostic biomarkers in endometrial cancer: a systematic review and meta-analysis. J Clin Med. 2020;9:1900.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grzywa TM, Sosnowska A, Matryba P, Rydzynska Z, Jasinski M, Nowis D, Golab J. Myeloid cell-derived arginase in cancer immune response. Front Immunol. 2020;11:938.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bronte V, Zanovello P. Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol. 2005;5:641–54.

Article  CAS  PubMed  Google Scholar 

Daikoku T, Hirota Y, Tranguch S, Joshi AR, DeMayo FJ, Lydon JP, et al. Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice. Can Res. 2008;68:5619–27.

Article  CAS  Google Scholar 

Kim TH, Wang J, Lee KY, Franco HL, Broaddus RR, Lydon JP, et al. The synergistic effect of conditional Pten loss and oncogenic K-ras mutation on endometrial cancer development occurs via decreased progesterone receptor action. J Oncol. 2010;2010:139087.

Article  PubMed  Google Scholar 

Fedorko AM, Kim TH, Broaddus R, Schmandt R, Chandramouli GVR, Kim HI, et al. An immune competent orthotopic model of endometrial cancer with metastasis. Heliyon. 2020;6:e04075.

Article  PubMed  PubMed Central  Google Scholar 

Marquardt RM, Kim TH, Yoo JY, Teasley HE, Fazleabas AT, Young SL, et al. Endometrial epithelial ARID1A is critical for uterine gland function in early pregnancy establishment. FASEB J. 2021;35:e21209.

Article  CAS  PubMed  Google Scholar 

Kim BG, Yoo J-Y, Kim TH, Shin J-H, Langenheim JF, Ferguson SD, et al. Aberrant activation of signal transducer and activator of transcription-3 (STAT3) signaling in endometriosis. Hum Reprod. 2015;30:1069–78.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ishibashi H, Suzuki T, Suzuki S, Moriya T, Kaneko C, Takizawa T, et al. Sex steroid hormone receptors in human thymoma. J Clin Endocrinol Metab. 2003;88:2309–17.

Article  CAS  PubMed  Google Scholar 

Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, et al. TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2016;44:e71–e71.

Article